Poalen Tablets (Sodium Alendronate Trihydrate)

Adult dose

As sodium alendronate, take 70 mg once a week in the morning at least 30 minutes before consuming food, beverages, or other medications with a sufficient amount of water (170-230 mL). After taking it, the patient should not lie down for at least 30 minutes and should not take it before bedtime or upon waking. If the designated dose is missed, take 70 mg the following morning.

This medication may cause stomach irritation, so patients with upper gastrointestinal disorders such as gastritis, esophagitis, or esophageal ulcers should take caution while using it. After taking this medication, inflammation or ulcers may occur in the esophagus, and in rare cases, severe problems such as esophageal obstruction or perforation may occur; if symptoms appear, the patient should cease taking the medication immediately and consult a physician. When taking this medication, it should be taken with a sufficient amount of water, and the patient should avoid lying down for at least 30 minutes after taking it. Failure to follow the proper administration methods increases the risk of esophageal irritation. Patients with esophageal motility disorders, those who cannot sit or stand upright, patients allergic to this medication or its components, patients with hypocalcemia, severe renal failure, pregnant or nursing women, and individuals with congenital lactose intolerance should not take this medication. While taking this medication, reactions such as abdominal pain, indigestion, nausea, constipation, diarrhea, acid reflux, esophageal ulcers, muscle or joint pain, headaches, dizziness, and skin rashes may occur; any unusual symptoms should be reported to a physician. Especially with long-term use, rare occurrences of stress fractures in bones may arise, so if pain persists, an examination is necessary. This medication is necessary to supplement calcium or vitamin D if they are deficient, and when taking calcium supplements or antacids together, a minimum interval of 30 minutes should be maintained to prevent impediment to absorption of the medication. Pregnant or nursing women should not take this medication, and the safety and efficacy for children and adolescents under 18 years old have not been established. Elderly patients can also take this medication, but caution is necessary as some elderly may be more sensitive to the drug. In case of overdose, symptoms such as hypocalcemia and gastrointestinal disturbances may occur, and vomiting should not be induced; the patient should be kept in an upright position. This medication should be stored out of the reach of children, and care should be taken to avoid transferring it to another container to prevent accidents or degradation of quality.

Serious side effects

Hives, angioedema (severe swelling), cold sweat, pallor, esophagitis, esophageal erosion, esophageal ulcers, esophageal stricture, esophageal perforation, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), gastric ulcers and duodenal ulcers (including severe rash, blisters, skin peeling, pain in mouth/eye mucous membranes), symptoms of hypocalcemia, peripheral edema, severe swelling, severe headache, seizures, confusion, vision abnormalities, paralysis, blood pressure changes.

Mild side effects

Abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, acid reflux, esophageal ulcers, vomiting, difficulty swallowing, abdominal bloating, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, alteration in taste, rash, itching, hair loss, scleritis, cholesteatoma of the external auditory canal.

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is advisable to keep it in a cool place between 15 to 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication over time.

Appearance

White oval-shaped tablet

Package unit

4 tablets (4 tablets/PTP packaging (AluAlu)x1)